Company Filing History:
Years Active: 2014
Title: Lixia Xu: Innovator in Gastric Cancer Diagnosis and Treatment
Introduction
Lixia Xu is a prominent inventor based in Hong Kong, CN. She has made significant contributions to the field of medical diagnostics, particularly in the area of gastric cancer. Her innovative work has led to the development of a method that aids in the diagnosis and prognosis of this serious disease.
Latest Patents
Lixia Xu holds 1 patent for her invention titled "Biomarker for gastric cancer." This patent provides a method for diagnosing and determining the prognosis of gastric cancer in a subject by detecting suppressed expression of the BCL6B gene. In some cases, this suppression is attributed to elevated methylation levels in the genomic sequence of this gene. The invention also includes a kit and device useful for implementing this diagnostic method. Furthermore, it offers a method for treating gastric cancer by increasing BCL6B gene expression or activity.
Career Highlights
Lixia Xu is affiliated with The Chinese University of Hong Kong, where she continues her research and development efforts. Her work is instrumental in advancing the understanding and treatment of gastric cancer, which remains a critical health issue worldwide.
Collaborations
Lixia Xu collaborates with esteemed colleagues, including Jun Yu and Joseph Jao Yiu Sung. Their combined expertise enhances the research and development of innovative solutions in cancer diagnostics and treatment.
Conclusion
Lixia Xu's contributions to the field of gastric cancer diagnosis and treatment exemplify her dedication to medical innovation. Her work not only aids in early detection but also opens new avenues for therapeutic interventions.